ECM Profile and Excellence: A History of Growth
ECM Profile and Excellence: A History of Growth
ECM boasts a solid, multi-year track record in medical device certification, consolidated through years of activity under the MDD Directive and, since October 14, 2022, as a Notified Body for the MDR Regulation.
To support this expertise, the company features a state-of-the-art headquarters that houses an ISO 17025 accredited testing laboratory, equipped with a cutting-edge semi-anechoic chamber.
Responsiveness and Operational Capacity at the Service of Time-to-Market
In contrast to a regulatory landscape where many manufacturers struggle to find placement, ECM currently has the operational capacity required to accept new clients and welcome new MDR applications from medical device manufacturers.
Thanks to a dynamic structure and a strongly customer-oriented approach, ECM stands out for its remarkable flexibility and responsiveness. The entire compliance process — from the initial assessment to the planning of activities — is structured to respond promptly through a structured and transparent dialogue with manufacturers. The focus is increasingly strategic and aimed at optimizing companies' time-to-market, reducing bureaucratic waiting times without ever compromising on the highest technical rigor.
In addition to standard procedures, the Notified Body is authorized to issue CE certifications in accordance with Article 22, as well as to provide Notified Body Opinions (Art. 117).
The Support of ECM and the Normec Group
Service efficiency is further enhanced by ECM joining the Normec Group. This major synergy is driving rapid corporate growth and a steady expansion of the specialized technical staff, ensuring efficient and professional support for EU and ISO 13485 Certification.
The combination of advanced testing activities in our ISO 17025 accredited laboratory, expertise in ISO 13485 management systems certification, and the solidity of a large international group allows ECM to position itself as the ideal partner. A solid point of reference, capable of guaranteeing medical sector companies total operational continuity, commercial security, and a smooth transition to the new European regulatory landscape.